Macy's, Inc.

Fundamentals5.0
Price Action6.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Earnings collapse
  • Cash drain
  • Inventory build

AI
AI Summary

6.0

Macy's is a turnaround with upside if store reformatting, Bloomingdale's luxury lifts, and omnichannel improvements rapidly restore free cash flow and inventory turns, but the investment is materially fragile—negative FCF, high leverage and a large inventory build make recovery the decisive catalyst or else force asset sales/dividend/buyback cuts.

Turnaround
Leverage
Inventory‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

5.0

Key Financial Insights:

  • Earnings collapse
  • Cash drain
  • Inventory build

Earnings and free cash flow have collapsed while cash, liquidity and margins weakened and inventory and leverage rose, making the dividend unsustainable and the investment case risky until profitability and cash conversion recover.

WeakLiquidity
Undervalued

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Below SMA
  • Neutral RSI
  • Support watch

Last month trend is down—close $17.87 sits below the ~$18.61 SMA, RSI ~43 is neutral-weak, with support at $16.92 (break = more downside) and resistance $20.00–$22.16 (reclaiming it would signal reversal).

weak
consolidating
Support Level: $16.92
Resistance Level: $20.00–$22.16

Material pullback from $22.16 to $17.87 over

Sentiment & News

6.0

Key News Insights:

  • Q4 outperformance
  • Strategic reshaping
  • Divergent ownership

Macy's delivered better‑than‑expected Q4 results and operational upside tied to its "Reimagine" strategy and attractive valuation, amid mixed investor positioning and market volatility, while a separate issuer using ticker M (Myriad Uranium) completed a small asset sale.

Value
AssetSale

Positive near‑term sentiment and valuation support could stabilize the stock despite longer‑term revenue headwinds, while the Myriad Uranium sale is a standalone, low‑impact asset monetization